Galectin 3 and Its Binding Protein in Rheumatoid Arthritis

Arthritis and Rheumatism

Volumn 48, Issue 10, 2003, Pages 2788-2795

  Ohshima, Shiro ^a,b   Kuchen, Stefan ^a   Seemayer, Christian A ^a   Kyburz, Diego ^a   Hirt, Astrid ^a   Klinzing, Stephanie ^a   Michel, Beat A ^a   Gay, Renate E ^a   Liu, Fu Tong ^c   Gay, Steffen ^a   Neidhart, Michel ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD40 LIGAND MONOCLONAL ANTIBODY; CYTOKINE; GALECTIN 3; GALECTIN 3 BINDING PROTEIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARRIER PROTEINS; CELL ADHESION; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; GALECTIN 3; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; INTERLEUKIN-1; OSTEOARTHRITIS; RNA, MESSENGER; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 0142135687     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11287     Document Type: Article

References (46)

1. Lorenz HM, Herrmann M, Kalden JR. The pathogenesis of autoimmune diseases. Scand J Clin Lab Invest Suppl 2001;235:16-26.
2. Rissoan MC, van Kooten C, Chomarat P, Galibert L, Durand I, Thivolet-Bejui F, et al. The functional CD40 antigen of fibroblasts may contribute to the proliferation of rheumatoid synovium. Clin Exp Immunol 1996;106:481-90.
3. Rinaldi N, Schwarz-Eywill M, Weis D, Leppelmann-Jansen P, Lukoschek M, Keilholz U, et al. Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins. Ann Rheum Dis 1997;56:45-51.
4. Neidhart M, Rethage J, Kuchen S, Kunzler P, Crowl RM, Billingham ME, et al. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum 2000;43:2634-47.
5. Seki T, Selby J, Haupl T, Winchester R. Use of differential subtraction method to identify genes that characterize the phenotype of cultured rheumatoid arthritis synoviocytes. Arthritis Rheum 1998;41:1356-64.
6. Nangia-Makker P, Sarvis R, Visscher DW, Bailey-Penrod J, Raz A, Sarkar FH. Galectin-3 and L1 retrotransposons in human breast carcinomas. Breast Cancer Res Treat 1998;49:171-83.
7. Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, Yamanaka T, et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 2000;165:2156-64.
8. Perillo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 1998;76:402-12.
9. Hughes RC. Galectins as modulators of cell adhesion. Biochimie 2001;83:667-76.
10. Wada J, Makino H. Galectins, galactoside-binding mammalian lectins: clinical application of multi-functional proteins. Acta Med Okayama 2001;55:11-7.
11. Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta 2002;1572:263-73.
12. Sanjuan X, Fernandez PL, Castells A, Castronovo V, van den Brule F, Liu FT, et al. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology 1997;113:1906-15.
13. Andre S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K, et al. Galectins-1 and -3 and their ligands in tumor biology: non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity. J Cancer Res Clin Oncol 1999;125:461-74.
14. Ellerhorst J, Troncoso P, Xu XC, Lee J, Lotan R. Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer. Urol Res 1999;27:362-7.
15. Plzak J, Smetana K Jr, Betka J, Kodet R, Kaltner H, Gabius HJ. Endogenous lectins (galectins-1 and -3) as probes to detect differentiation-dependent alterations in human squamous cell carcinomas of the oropharynx and larynx. Int J Mol Med 2000;5:369-72.
16. Rabinovich GA, Sotomayor CE, Riera CM, Bianco I, Correa SG. Evidence of a role for galectin-1 in acute inflammation. Eur J Immunol 2000;30:1331-9.
17. Jeng KC, Frigeri LG, Liu FT. An endogenous lectin, galectin-3 (εBP/Mac-2), potentiates IL-1 production by human monocytes. Immunol Lett 1994;42:113-6.
18. Hsu DK, Yang RY, Pan Z, Yu L, Salomon DR, Fung-Leung WP, et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 2000;156:1073-83.
19. Xu XC, Sola Gallego JJ, Lotan R, El-Naggar AK. Differential expression of galectin-1 and galectin-3 in benign and malignant salivary gland neoplasms. Int J Oncol 2000;17:271-6.
20. Lotz MM, Andrews CW Jr, Korzelius CA, Lee EC, Steele GD Jr, Clarke A, et al. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci U S A 1993;90:3466-70.
21. Castronovo V, van den Brule FA, Jackers P, Clausse N, Liu FT, Gillet C, et al. Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol 1996;179:43-8.
22. Konstantinov KN, Robbins BA, Liu FT. Galectin-3, a β -galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma. Am J Pathol 1996;148:25-30.
23. Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 1997;80:776-87.
24. Fernandez PL, Merino MJ, Gomez M, Campo E, Medina T, Castronovo V, et al. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 1997;181:80-6.
25. Coli A, Bigotti G, Zucchetti F, Negro F, Massi G. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology 2002;40:80-7.
26. Juliao SF, Rand N, Schwartz HS. Galectin-3: a biologic marker and diagnostic aid for chordoma. Clin Orthop 2002;397:70-5.
27. Song YK, Billiar TR, Lee YJ. Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide. Am J Pathol 2002;160:1069-75.
28. Neidhart M, Hauser N, Paulsson M, DiCesare PE, Michel BA, Häuselmann HJ. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 1997;36:1151-60.
29. Kühne SAM, Neidhart M, Everson MP, Häntzschel H, Fine PR, Gay S, et al. Persistent high serum levels of cartilage oligomeric matrix protein in a subgroup of patients with traumatic knee injury. Rheumatol Int 1998;18:21-5.
30. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
31. Kuwabara I, Liu FT. Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 1996;156:3939-44.
32. Yang RY, Hsu DK, Liu FT. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A 1996;93:6737-42.
33. Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, Raz A. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 2002;277:6852-7.
34. Pricci F, Leto G, Amadio L, Iacobini C, Romeo G, Cordone S, et al. Role of galectin-3 as a receptor for advanced glycosylation end products. Kidney Int Suppl 2000;77:S31-9.
35. Hellstern S, Sasaki T, Fauser C, Lustig A, Timpl R, Engel J. Functional studies on recombinant domains of Mac-2-binding protein. J Biol Chem 2002;277:15690-6.
36. Marchetti A, Tinari N, Buttitta F, Chella A, Angeletti CA, Sacco R, et al. Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Cancer Res 2002;62:2535-9.
37. Koths K, Taylor E, Halenbeck R, Casipit C, Wang A. Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J Biol Chem 1993;268:14245-9.
38. Sasaki T, Brakebusch C, Engel J, Timpl R. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds β1 integrins, collagens and fibronectin. EMBO J 1998;17:1606-13.
39. Harjacek M, Diaz-Cano S, de Miguel M, Wolfe H, Maldonado CA, Rabinovich GA. Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis. J Rheumatol 2001;28:1914-22.
40. Iacobelli S, Sismondi P, Giai M, D'Egidio M, Tinari N, Amatetti C, et al. Prognostic value of a novel circulating serum 90K antigen in breast cancer. Br J Cancer 1994;69:172-6.
41. Zeimet AG, Natoli C, Herold M, Fuchs D, Windbichler G, Daxenbichler G, et al. Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer. Int J Cancer 1996;68:34-8.
42. Fornarini B, D'Ambrosio C, Natoli C, Tinari N, Silingardi V, Iacobelli S. Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo. Blood 2000;96:3282-5.
43. Groschel B, Braner JJ, Funk M, Linde R, Doerr HW, Cinatl J Jr, et al. Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children. J Clin Immunol 2000;20:117-22.
44. Benvenuto G, Carpentieri ML, Salvatore P, Cindolo L, Bruni CB, Chiariotti L. Cell-specific transcriptional regulation and reactivation of galectin-1 gene expression are controlled by DNA methylation of the promoter region. Mol Cell Biol 1996;16:2736-43.
45. Jensen-Jarolim E, Gscheidlinger R, Oberhuber G, Neuchrist C, Lucas T, Bises G, et al. The constitutive expression of galectin-3 is downregulated in the intestinal epithelia of Crohn's disease patients, and tumour necrosis factor a decreases the level of galectin-3-specific mRNA in HCT-8 cells. Eur J Gastroenterol Hepatol 2002;14:145-52.
46. Franz JK, Kolb SA, Hummel KM, Lahrtz F, Neidhart M, Aicher WK, et al. Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis. Eur J Immunol 1998;28:2661-71.